HEADER HYDROLASE/HYDROLASE INHIBITOR 12-SEP-12 3VXE TITLE HUMAN ALPHA-THROMBIN-BIVALIRUDIN COMPLEX AT PD5.0 COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 EC: 3.4.21.5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 7 CHAIN: H; COMPND 8 EC: 3.4.21.5; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: BIVALIRUDIN; COMPND 11 CHAIN: J; COMPND 12 FRAGMENT: C-TERMINAL FRAGMENT; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 4; COMPND 15 MOLECULE: BIVALIRUDIN; COMPND 16 CHAIN: I; COMPND 17 FRAGMENT: N-TERMINAL FRAGMENT; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 MOL_ID: 3; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: FRAGMENT PRODUCED ENZYMATICALLY FROM BIVALIRUDIN; SOURCE 12 MOL_ID: 4; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: FRAGMENT PRODUCED ENZYMATICALLY FROM BIVALIRUDIN KEYWDS SERINE PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.YAMADA,K.KURIHARA,K.MASUMI,T.TAMADA,K.TOMOYORI,Y.OHNISHI,I.TANAKA, AUTHOR 2 R.KUROKI,N.NIIMURA REVDAT 4 30-OCT-24 3VXE 1 REMARK REVDAT 3 08-NOV-23 3VXE 1 HETSYN REVDAT 2 29-JUL-20 3VXE 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE REVDAT 1 04-SEP-13 3VXE 0 JRNL AUTH T.YAMADA,K.KURIHARA,Y.OHNISHI,T.TAMADA,K.TOMOYORI,K.MASUMI, JRNL AUTH 2 I.TANAKA,R.KUROKI,N.NIIMURA JRNL TITL NEUTRON AND X-RAY CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN JRNL TITL 2 ALPHA-THROMBIN-BIVALIRUDIN COMPLEX AT PD 5.0: PROTONATION JRNL TITL 3 STATES AND HYDRATION STRUCTURE OF THE ENZYME-PRODUCT COMPLEX JRNL REF BIOCHIM.BIOPHYS.ACTA V.1834 1532 2013 JRNL REFN ISSN 0006-3002 JRNL PMID 23712263 JRNL DOI 10.1016/J.BBAPAP.2013.05.014 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.2 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.144 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.144 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4973 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 99805 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.136 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.170 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 4281 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 81458 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2366 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 284 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2659.9 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 9 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 24499 REMARK 3 NUMBER OF RESTRAINTS : 0 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 ANGLE DISTANCES (A) : 0.030 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.387 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.028 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.089 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3VXE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000095619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-5A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 100096 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 40.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRYT 1TMT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% W/V PEG 4000, 100MM SODIUM ACETATE REMARK 280 PD5.0 AT ROOM TEMPERATURE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K, PH 5.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 39.89350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.30900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.89350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.30900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, J, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H1090 LIES ON A SPECIAL POSITION. REMARK 375 HOH H1143 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE BIVALIRUDIN N-TERMINUS FRAGMENT IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 THROMBIN INHIBITOR CLASS. REMARK 400 REMARK 400 THE BIVALIRUDIN C-TERMINUS FRAGMENT IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 THROMBIN INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: BIVALIRUDIN N-TERMINUS FRAGMENT REMARK 400 CHAIN: J REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 400 REMARK 400 GROUP: 2 REMARK 400 NAME: BIVALIRUDIN C-TERMINUS FRAGMENT REMARK 400 CHAIN: I REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR L 1H REMARK 465 PHE L 1G REMARK 465 GLY L 1F REMARK 465 SER L 1E REMARK 465 GLY L 1D REMARK 465 ILE L 14K REMARK 465 ASP L 15 REMARK 465 GLY L 16 REMARK 465 ARG L 17 REMARK 465 GLY H 246 REMARK 465 GLU H 247 REMARK 465 PRO J 48 REMARK 465 GLY J 49 REMARK 465 GLY J 50 REMARK 465 GLY J 51 REMARK 465 GLY J 52 REMARK 465 ASN J 53 REMARK 465 GLY J 54 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU L 1C CG CD OE1 OE2 REMARK 470 LYS L 14A CD CE NZ REMARK 470 TYR L 14J O REMARK 470 GLU H 39 CG CD OE1 OE2 REMARK 470 LYS H 81 CD CE NZ REMARK 470 LYS H 87 CE NZ REMARK 470 GLU H 97A CG CD OE1 OE2 REMARK 470 LYS H 110 CD CE NZ REMARK 470 LYS H 149E CG CD CE NZ REMARK 470 ARG H 233 CG CD NE CZ NH1 NH2 REMARK 470 LYS H 236 CD CE NZ REMARK 470 GLN H 239 CD OE1 NE2 REMARK 470 LYS H 240 CE NZ REMARK 470 GLN H 244 CD OE1 NE2 REMARK 470 ASP J 55 CG OD1 OD2 REMARK 470 GLU J 62 CD OE1 OE2 REMARK 470 LEU J 64 C O CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG L 4 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG L 14D NH1 - CZ - NH2 ANGL. DEV. = -7.6 DEGREES REMARK 500 ARG L 14D NE - CZ - NH1 ANGL. DEV. = 7.1 DEGREES REMARK 500 TYR L 14J CA - CB - CG ANGL. DEV. = 12.9 DEGREES REMARK 500 TYR L 14J CB - CG - CD2 ANGL. DEV. = 4.5 DEGREES REMARK 500 TYR L 14J CZ - CE2 - CD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG H 50 CG - CD - NE ANGL. DEV. = 14.3 DEGREES REMARK 500 ARG H 50 CD - NE - CZ ANGL. DEV. = -8.4 DEGREES REMARK 500 ARG H 73 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG H 75 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG H 75 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG H 77A NE - CZ - NH1 ANGL. DEV. = -4.0 DEGREES REMARK 500 TRP H 96 O - C - N ANGL. DEV. = 11.3 DEGREES REMARK 500 ARG H 97 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ARG H 101 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 TYR H 134 CB - CG - CD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 TYR H 134 CB - CG - CD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG H 165 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG H 165 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 ARG H 175 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG H 187 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG H 221A NE - CZ - NH1 ANGL. DEV. = -4.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE L 7 -87.10 -129.12 REMARK 500 ALA H 44 -178.98 -170.61 REMARK 500 TYR H 60A 82.13 -154.29 REMARK 500 ASN H 60G 88.97 -155.72 REMARK 500 HIS H 71 -64.47 -130.86 REMARK 500 ILE H 79 -61.04 -122.93 REMARK 500 GLU H 97A -99.33 -114.81 REMARK 500 GLU H 97A -55.66 72.93 REMARK 500 ASN H 98 11.91 -145.19 REMARK 500 ASN H 204B 13.03 -146.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3VXF RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 BIVALIRUDIN IS HYDROLYZED AT ARG3-PRO4 BOND DURING CRYSTALLIZATION REMARK 999 AND BECOMES TWO CHAINS. THE COMPLETE SEQUENCE OF BIVALIRUDIN IS REMARK 999 (DPN)PRPGGGGNGDFEEIPEEYL. DBREF 3VXE L 1H 17 UNP P00734 THRB_HUMAN 328 363 DBREF 3VXE H 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 3VXE J 48 64 PDB 3VXE 3VXE 48 64 DBREF 3VXE I 1 3 PDB 3VXE 3VXE 1 3 SEQRES 1 L 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 L 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 L 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 H 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 H 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 H 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 H 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 J 17 PRO GLY GLY GLY GLY ASN GLY ASP PHE GLU GLU ILE PRO SEQRES 2 J 17 GLU GLU TYR LEU SEQRES 1 I 3 DPN PRO ARG MODRES 3VXE ASN H 60G ASN GLYCOSYLATION SITE HET DPN I 1 11 HET NAG H 300 14 HETNAM DPN D-PHENYLALANINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 DPN C9 H11 N O2 FORMUL 5 NAG C8 H15 N O6 FORMUL 6 HOH *284(H2 O) HELIX 1 1 PHE L 7 SER L 11 5 5 HELIX 2 2 THR L 14B TYR L 14J 1 9 HELIX 3 3 ALA H 55 CYS H 58 5 4 HELIX 4 4 PRO H 60B ASP H 60E 5 4 HELIX 5 5 THR H 60I ASN H 62 5 3 HELIX 6 6 ASP H 125 LEU H 130 1 9 HELIX 7 7 GLU H 164 SER H 171 1 8 HELIX 8 8 LYS H 185 GLY H 186C 5 5 HELIX 9 9 LEU H 234 PHE H 245 1 12 HELIX 10 10 PRO J 60 LEU J 64 5 5 SHEET 1 A 8 SER H 20 ASP H 21 0 SHEET 2 A 8 GLN H 156 VAL H 163 -1 O VAL H 157 N SER H 20 SHEET 3 A 8 MET H 180 ALA H 183 -1 O CYS H 182 N VAL H 163 SHEET 4 A 8 GLY H 226 HIS H 230 -1 O TYR H 228 N PHE H 181 SHEET 5 A 8 TRP H 207 TRP H 215 -1 N TRP H 215 O PHE H 227 SHEET 6 A 8 PRO H 198 LYS H 202 -1 N MET H 201 O TYR H 208 SHEET 7 A 8 LYS H 135 GLY H 140 -1 N ARG H 137 O VAL H 200 SHEET 8 A 8 GLN H 156 VAL H 163 -1 O VAL H 158 N VAL H 138 SHEET 1 B 7 GLN H 30 ARG H 35 0 SHEET 2 B 7 GLU H 39 LEU H 46 -1 O CYS H 42 N LEU H 33 SHEET 3 B 7 TRP H 51 THR H 54 -1 O LEU H 53 N SER H 45 SHEET 4 B 7 ALA H 104 LEU H 108 -1 O ALA H 104 N THR H 54 SHEET 5 B 7 LYS H 81 ILE H 90 -1 N GLU H 86 O LYS H 107 SHEET 6 B 7 LEU H 64 ILE H 68 -1 N ILE H 68 O LYS H 81 SHEET 7 B 7 GLN H 30 ARG H 35 -1 N PHE H 34 O LEU H 65 SHEET 1 C 2 LEU H 60 TYR H 60A 0 SHEET 2 C 2 LYS H 60F ASN H 60G-1 O LYS H 60F N TYR H 60A SSBOND 1 CYS L 1 CYS H 122 1555 1555 2.05 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.05 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.03 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.05 LINK ND2 ASN H 60G C1 NAG H 300 1555 1555 1.45 LINK C DPN I 1 N PRO I 2 1555 1555 1.32 CISPEP 1 SER H 36A PRO H 37 0 -10.80 CRYST1 79.787 106.618 45.574 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012533 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009379 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021942 0.00000